Table 1 Cox regression for time to progression to MM
Variables | n/N (%) | Time to treatment for MM | |
|---|---|---|---|
HR (95% CI) | P-value | ||
Univariate | |||
 Age ⩾65 years | 49/110 (45%) | 3.49 (1.58, 7.69) | <0.001 |
 Female | 52/110 (47%) | 0.67 (0.32, 1.42) | 0.295 |
 White | 91/110 (83%) | 7.11 (0.97, 52.24) | 0.024 |
 Albumin<3.5 g/dl | 21/110 (19%) | 4.39 (2.10, 9.15) | <0.001 |
 B2M ⩾3.5 mg/l | 32/109 (29%) | 2.85 (1.37, 5.92) | 0.003 |
 B2M>5.5 mg/l | 6/109 (6%) | 1.54 (0.37, 6.50) | 0.552 |
 Creatinine ⩾2 mg/dl | 1/110 (1%) | 0.00 (0.00) | 0.562 |
 CRP ⩾8 mg/l | 28/110 (25%) | 0.83 (0.34, 2.04) | 0.685 |
 Hb<10 g/dl | 4/110 (4%) | 4.23 (1.26, 14.14) | 0.011 |
 LDH ⩾190 U/l | 12/110 (11%) | 0.69 (0.16, 2.91) | 0.614 |
 M Protein ⩾3 g/dl | 17/109 (16%) | 7.52 (3.58, 15.82) | <0.001 |
 BMPC ⩾10% | 72/110 (65%) | 5.43 (1.64, 17.96) | 0.002 |
 Involved light chain>10 mg/dl | 32/86 (37%) | 1.56 (0.73, 3.34) | 0.248 |
 Involved/uninvolved ratio>8 | 45/86 (52%) | 2.51 (1.10, 5.75) | 0.024 |
 Cytogenetic abnormalities | 18/110 (16%) | 3.83 (1.77, 8.27) | <0.001 |
 GEP 70-gene risk>−0.26 | 28/84 (33%) | 6.39 (2.59, 15.77) | <0.001 |
 GEP 4-gene score⩾9.28 | 10/84 (12%) | 7.57 (3.14, 18.26) | <0.001 |
 Number of stem lines⩾2 | 64/110 (58%) | 3.29 (1.34, 8.10) | 0.006 |
 Any aneuploidy | 70/110 (64%) | 2.52 (1.03, 6.19) | 0.037 |
 Total LCR% >17 | 20/110 (18%) | 10.92 (5.14, 23.16) | <0.001 |
 Any CIg<3.6 | 26/110 (24%) | 7.90 (3.75, 16.66) | <0.001 |
Multivariate | |||
 M Protein ⩾3 g/dl | 17/109 (16%) | 4.57 (2.08, 10.04) | <0.001 |
 Total LCR% >17 | 20/109 (18%) | 4.72 (2.07, 10.76) | <0.001 |
 Any CIg<3.6 | 26/109 (24%) | 3.97 (1.75, 8.99) | <0.001 |